Biomerica
BMRA
34 hedge funds and large institutions have $8.83M invested in Biomerica in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
13% more funds holding
Funds holding: 30 → 34 (+4)
0.27% more ownership
Funds ownership: 3.24% → 3.51% (+0.27%)
23% less capital invested
Capital invested by funds: $11.5M → $8.83M (-$2.65M)
94% less call options, than puts
Call options by funds: $1K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Potomac Capital Management
New York
|
+$1.16M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.08M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$694K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$298K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
+$199K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$512K |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$63.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$51.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$50.4K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$40.7K |
BMRA Hedge Fund Activity: Q1 2023 in Review
34 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q1 2023, worth a combined $8.83M — down 23% from $11.5M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BMRA positions and 2 closed out — a net gain of 5 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Potomac Capital Management, opening a new position worth an estimated $1.16M. The largest seller was Point72 Asset Management, cutting an estimated $512K.
- 34 institutional investors held Biomerica (BMRA) as of Q1 2023, up from 30 in Q4 2022.
- Funds reported $8.83M of Biomerica stock for Q1 2023, down 23% quarter-over-quarter.
- 7 funds opened new Biomerica positions in Q1 2023 and 2 closed out, a net change of +5 holders.
- The largest Biomerica buyer in Q1 2023 was Potomac Capital Management, an estimated $1.16M added.
- The largest Biomerica seller in Q1 2023 was Point72 Asset Management, an estimated $512K sold.
Based on aggregated 13F filings for Q1 2023.